Beijing Wantai Biopharmaceutical Co., Ltd. (hereinafter referred to as Wantai Biopharmaceutical) was established in 1991. It is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines. With the pursuit of "contributing to the cause of human health", the company is committed to transforming biotechnology achievements into high-quality products to serve the public.

The company has seven subsidiaries, and its products cover multiple fields such as enzyme rabbits, colloidal gold, chemiluminescence, nucleic acid detection, biochemistry, vaccines and quality control products.

In 2005, with the approval of the Ministry of Science and Technology, Yangshengtang Wantai Biology and Xiamen University jointly established the National Center for Diagnostic Reagents and Vaccine Engineering Technology (NIDVD). The center has built an indispensable bridge between product research and development and industrialization, becoming an industrial incubator that effectively undertakes relevant R&D achievements across the country and even internationally, accelerating the speed of diagnostic reagents and vaccine research and development products entering the market, and shortening the product transformation cycle. This has made great progress in China's infectious disease diagnostic reagents and vaccine industries.

Beijing Wantai Biopharma Co., Ltd. takes "science-based, health-oriented" as its corporate development concept, adheres to the purpose of "survival with quality and development with scientific and technological innovation", and is committed to contributing to the cause of human health. It will also write a brilliant chapter in the development history of China's diagnostic reagents and vaccines!